Filing Details
- Accession Number:
- 0001209191-11-029540
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-18 19:55:53
- Reporting Period:
- 2011-05-09
- Filing Date:
- 2011-05-18
- Accepted Time:
- 2011-05-18 19:55:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920465 | La Jolla Pharmaceutical Co | LJPC | Biological Products, (No Disgnostic Substances) (2836) | 330361285 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1354737 | Deirdre Gillespie | 4365 Executive Drive, Suite 300 San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-05-09 | 99,166 | $0.01 | 99,166 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-05-17 | 99,166 | $0.02 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common | Series C-1 Convertible Preferred | Disposition | 2011-05-09 | 1 | $595.00 | 99,166 | $0.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
111 | No | 4 | M | Direct |
Footnotes
- Shares issued on conversion of Series C-1 Convertible Preferred. The Series C-1 Convertible Preferred has a face value of $1,000 per share and was convertible into Common Stock at a ratio of 166,667 shares of Common Stock per share of Series C-1 Convertible Preferred.
- Reflects the price following a one-time adjustment on May 7, 2011 after the Company's 100 to 1 reverse split.
- Exercisable date is not applicable.
- Expiration date is not applicable.